ArticleProceedings of the National Academy of Sciences of the United States of America2014

Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Cédric Lecoutey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.